Published in CMAJ on October 28, 2013
Unusual venous thrombosis. CMAJ (2014) 0.75
Venous thrombosis: a multicausal disease. Lancet (1999) 5.41
Systematic review: the Trousseau syndrome revisited: should we screen extensively for cancer in patients with venous thromboembolism? Ann Intern Med (2008) 3.56
Risk assessment for recurrent venous thrombosis. Lancet (2010) 3.31
Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA (2005) 3.04
Utility of clinical examination in the diagnosis of emergency department patients admitted to the department of medicine of an academic hospital. Arch Intern Med (2011) 2.64
Extensive screening for occult malignant disease in idiopathic venous thromboembolism: a prospective randomized clinical trial. J Thromb Haemost (2004) 2.28
Clinical guidelines for testing for heritable thrombophilia. Br J Haematol (2010) 1.79
Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management. Am J Hematol (2012) 1.45
Does thrombophilia testing help in the clinical management of patients? Br J Haematol (2008) 1.07
Guidelines on the investigation and management of venous thrombosis at unusual sites. Br J Haematol (2012) 1.07
Duration of anticoagulant therapy after a first episode of an unprovoked pulmonary embolus or deep vein thrombosis: guidance from the SSC of the ISTH. J Thromb Haemost (2012) 1.06
Disease characteristics and clinical outcome in young adults with essential thrombocythemia versus early/prefibrotic primary myelofibrosis. Blood (2012) 1.04
The JAK2 V617F mutation and thrombosis. Br J Haematol (2008) 0.97
Etiology and VTE risk factor distribution in patients with inferior vena cava thrombosis. Thromb Res (2008) 0.94
Etiology of thrombocytosis in a general medicine population: analysis of 801 cases with emphasis on infectious causes. J Clin Med Res (2012) 0.88
Utility of clinical examination in the diagnosis of emergency department patients admitted to the department of medicine of an academic hospital. Arch Intern Med (2011) 2.64
Bartonella koehlerae, a new cat-associated agent of culture-negative human endocarditis. J Clin Microbiol (2004) 1.72
What do patients really want to know? QJM (2002) 1.49
Early readmissions to the department of medicine as a screening tool for monitoring quality of care problems. Medicine (Baltimore) (2008) 1.48
Tumor necrosis factor-alpha-induced insulin resistance may mediate the hepatitis C virus-diabetes association. Am J Gastroenterol (2003) 1.33
Virology, pathogenetic mechanisms, and associated diseases of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8). Mayo Clin Proc (2002) 1.07
Right heart failure and hyperthyroidism: a neglected presentation. Am J Med (2003) 0.93
Characterization of T-cell large granular lymphocyte leukemia associated with Sjogren's syndrome-an important but under-recognized association. Semin Arthritis Rheum (2006) 0.92
Predictors of adherence to inhaled medications. J Gen Intern Med (2013) 0.90
Enhancing the action of rituximab in chronic lymphocytic leukemia by adding fresh frozen plasma: complement/rituximab interactions & clinical results in refractory CLL. Ann N Y Acad Sci (2009) 0.90
Absence of Kaposi sarcoma among Ethiopian immigrants to Israel despite high seroprevalence of human herpesvirus 8. Mayo Clin Proc (2002) 0.83
Acute Splenic Infarction at an Academic General Hospital Over 10 Years: Presentation, Etiology, and Outcome. Medicine (Baltimore) (2015) 0.83
Routine chest X-ray on hospital admission: does it contribute to diagnosis or treatment? Isr Med Assoc J (2010) 0.78
Etanercept-associated transient bone marrow aplasia: a review of the literature and pathogenetic mechanisms. Drugs R D (2014) 0.77
Clinical aspects of chronic hepatitis C infection. JAMA (2003) 0.77
Polycystic ovary syndrome in post-menopausal women--marker of the metabolic syndrome. Maturitas (2005) 0.77
Low-dose pulsed intravenous cyclophosphamide for severe ocular cicatricial pemphigoid in elderly patients. Cornea (2014) 0.77
Review: bDMARDs are linked to increased risk for infection compared with conventional synthetic DMARDs in RA. Ann Intern Med (2014) 0.76
ACP Journal Club. Review: Strength training, with or without flexibility and aerobic training, reduces pain in lower limb osteoarthritis. Ann Intern Med (2013) 0.75
Review: In rheumatoid arthritis, TNF-α inhibitors do not differ from placebo or DMARDs for all-cause mortality. Ann Intern Med (2016) 0.75
Patient care outside of office visits. J Gen Intern Med (2011) 0.75
REAP: an extended agenda for the clinical interview. CMAJ (2006) 0.75
ACP Journal Club. Review: In rheumatoid arthritis, adding rituximab to methotrexate improves clinical outcomes. Ann Intern Med (2015) 0.75
Test appropriateness index. Am J Med (2012) 0.75
Warfarin-induced skin necrosis. J Gen Intern Med (2013) 0.75
Review: In RA, standard- and high-dose biologic drugs increase serious infection compared with traditional DMARDs. Ann Intern Med (2015) 0.75
Review: bDMARDs plus conventional synthetic DMARDs have greater efficacy than either alone in RA. Ann Intern Med (2014) 0.75
Lercanidipine-associated nocturia. QJM (2011) 0.75
On the clinical encounter with 'zebras' - the science and art of rare diseases. Eur J Intern Med (2011) 0.75
Parallel communication in the wards. Eur J Intern Med (2010) 0.75
Can a rare form of myasthenia gravis shed additional light on disease mechanisms? Clin Neurol Neurosurg (2012) 0.75
Compassionate optimism. Lancet (2010) 0.75
Pel-Ebstein cyclic fever: not just lymphoma. Am J Med (2010) 0.75
One blow too many. Am J Med (2004) 0.75
A 37-year-old man with a febrile illness. Staphylococcal toxic shock syndrome. Clin Infect Dis (2003) 0.75
Review: Some NSAIDs, notably diclofenac, improved knee or hip pain and function in osteoarthritis vs other NSAIDs. Ann Intern Med (2016) 0.75
Grave's disease and acquired hyposplenism. QJM (2009) 0.75
Age-adjusted survival gained by treatment: an alternative way of presenting survival. Am J Med (2005) 0.75
Patient-physician distance. Eur J Intern Med (2013) 0.75
Malignant ascites and bacterial peritonitis. Med J Aust (2006) 0.75
High impact grand mal. Postgrad Med J (2016) 0.75
Height loss and generalized pain in a 35-year-old man. Am J Med (2010) 0.75
Hypercalcemia in isolated hypothalamic-pituitary Langerhans cell histiocytosis with no bone lesions. Am J Med (2004) 0.75
Verteporfin and myocardial infarction. Ann Pharmacother (2003) 0.75